Elite Pharmaceuticals launches generic Norco (hydrocodone/acetaminophen) tablets

ELITE PHARMACEUTICALS INC /NV/

Launched generic Norco (hydrocodone bitartrate/acetaminophen) in 2.5/325, 5/325, 7.5/325, and 10/325 mg strengths.
Indicated for management of pain severe enough to require an opioid analgesic when alternatives are inadequate.
IQVIA reported annual sales of approximately $300M for the brand product for 12 months ending September 2024.
Product marketed and sold under the Elite Laboratories label.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.